Wainua 45 mg/0.8 mL single-dose autoinjector Images
Generic Name: eplontersen
This medication has been identified as Wainua 45 mg/0.8 mL single-dose autoinjector. It is supplied by AstraZeneca.
Wainua is used in the treatment of Transthyretin-Related Amyloidosis and belongs to the drug class miscellaneous metabolic agents. Wainua 45 mg/0.8 mL single-dose autoinjector is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Wainua
- Generic Name
- eplontersen
- Strength
- 45 mg/0.8 mL single-dose autoinjector
- Availability
- Prescription only
- Drug Class
- Miscellaneous metabolic agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca
- National Drug Code (NDC)
- 00310-9400
More about Wainua (eplontersen)
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous metabolic agents
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
